You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

51 Results
Guidelines and Advice
Status: Archived
ID: 6-14
Dec 2008
Guidelines and Advice
Status: Current
ID: GL-C50-09
Jun 2019
Guidelines and Advice
Status: Archived
ID: CED 8
Jul 2008
Guidelines and Advice
Status: Archived
ID: CED 10
Sep 2008
Guidelines and Advice
Status: Archived
ID: CED 7
Feb 2008
Guidelines and Advice
Status: Archived
ID: CED 9
Aug 2008
Guidelines and Advice
Status: Archived
ID: 1-13
Sep 2008
Guidelines and Advice
Status: Archived
ID: 3-19
Feb 2008
Guidelines and Advice
Status: Archived
ID: 16-2
Mar 2008
Guidelines and Advice
Status: Archived
ID: 6-9
Jan 2008
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Funding:
ODB - General Benefit
    dexamethasone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
gemcitabine,
CISplatin,
dexamethasone
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
DACTINomycin,
etoposide,
methotrexate,
leucovorin,
cyclophosphamide,
vinCRIStine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019

Pages